The 5 analysts offering 12-month price forecasts for Alpine Immune Sciences Inc have a median target of 21.00, with a high estimate of 27.00 and a low estimate of 18.00. The median estimate represents a +125.08% increase from the last price of 9.33.
The current consensus among 6 polled investment analysts is to Buy stock in Alpine Immune Sciences Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.34
Reporting Date Aug 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.